Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine vs Ropivacaine in Third Molar Removal Surgery
NCT07108465Phase 1Recruiting
- Start
- Jul 2025
- Primary completion
- Sep 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1 trial of ropivacaine and bupivacaine in third molar extraction (2 arms). Primary endpoints: Postoperative analgesic capacity using Visual Analog Scale up to 7 days, Intraoperative hemostasis and 1 more. Started Jul 2025; status: recruiting.
02
Drugs
ropivacainebupivacaine
03
Conditions
third molar extraction
Beyond the preview
Go deeper on NCT07108465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07108465.